SANGUINATE
Dead / Cancelled — Cancelled — Section 8 (as of 18 Nov 2022)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85091803
- Registration number
- 4136178
- Mark type
- Design + words
- Filed
- 23 Jul 2010
- Published for opposition
- 14 Dec 2010
- Registered
- 01 May 2012
- Attorney of record
- Erik M. Pelton
Goods and services
- Class 005 — Pharmaceuticals: Blood substitutes for veterinary and human use
Owner
- Prolong Pharmaceuticals, Inc., South Plainfield, NJ, US
- Prolong Pharmaceuticals, Inc., South Plainfield, NJ, US
- Prolong Pharmaceuticals, Inc., South Plainfield, NJ, US
Prior registrations
Prosecution history
- 18 Nov 2022 — CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
- 01 May 2021 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 15 May 2018 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 15 May 2018 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 11 May 2018 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 30 Apr 2018 — TEAS SECTION 8 & 15 RECEIVED
- 01 May 2017 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 01 May 2012 — REGISTERED-PRINCIPAL REGISTER
- 28 Mar 2012 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 27 Mar 2012 — LAW OFFICE REGISTRATION REVIEW COMPLETED
- 26 Mar 2012 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 05 Mar 2012 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 05 Mar 2012 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 24 Feb 2012 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 15 Sept 2011 — NOTIFICATION OF NON-FINAL ACTION E-MAILED